Seasoned investor and operator with a focus on growth-stage technology and healthcare opportunities, bringing experience across venture capital, corporate strategy and board advisory roles. Karen Tatman combines deal-sourcing and portfolio-management skills with operational insight to support scaling companies, capital raises and M&A execution. Regularly engages with founders and management teams on go-to-market, financial planning and governance; known for constructing syndicates and advising on exit pathways. Market-facing profile appeals to LPs seeking experienced GP collaboration and strategic value-add in complex sectors.
Seasoned investor and operator with a focus on growth-stage technology and healthcare opportunities, bringing experience across venture capital, corporate strategy and board advisory roles. Karen Tatman combines deal-sourcing and portfolio-management skills with operational insight to support scaling companies, capital raises and M&A execution. Regularly engages with founders and management teams on go-to-market, financial planning and governance; known for constructing syndicates and advising on exit pathways. Market-facing profile appeals to LPs seeking experienced GP collaboration and strategic value-add in complex sectors.
Targets growth-stage technology and healthcare companies, applying an operator-investor mindset that prioritizes revenue acceleration, capital efficiency and durable unit economics. Deploys conviction-led, staged capital with active board-level governance and hands-on go-to-market and financial planning support. Emphasizes syndicate construction, exit pathway optimization and LP alignment, favoring scalable models where operational leverage and M&A optionality shorten time to liquidity.
Targets growth-stage technology and healthcare companies, applying an operator-investor mindset that prioritizes revenue acceleration, capital efficiency and durable unit economics. Deploys conviction-led, staged capital with active board-level governance and hands-on go-to-market and financial planning support. Emphasizes syndicate construction, exit pathway optimization and LP alignment, favoring scalable models where operational leverage and M&A optionality shorten time to liquidity.
| Trades 55 | Longs Won 49/55 89% | Profit Factor 622.69 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2.91M |
| Average Win $981,951.7 | Best Trade (Jun 02) $16.19M | Sharpe Ratio -12.5 |
| Average Loss -$12,878.46 | Worst Trade (May 19) -$44,065.87 | Z-Score 19.35 (100%) |
| Commissions $0 | Avg. Trade Length 9m 3w 3d | Expectancy $873,424.77 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 1.01% |
| Consecutive Losing Trades | 16,393 | 14,754 | 13,115 | 11,475 | 9,836 | 8,197 | 6,557 | 4,918 | 3,279 | 1,639 |